Authors' response to letter to the editor, "The effects of eugenol nanoemulsion on pain caused by arteriovenous fistula cannulation in hemodialysis patients: A randomized double-blinded controlled cross-over clinical trial"

Affiliations

¹ Department of Persian Medicine, Fasa University of Medical Sciences, Fasa, Iran.
² Traditional Medicine and Hydrotherapy Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
³ Department of Obstetrics and Gynecology, Richmond University Medical Center, Staten Island, New York, USA.
⁴ Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran; Department of Persian Medicine, Fasa University of Medical Sciences, Fasa, Iran. Electronic address: hashempur@gmail.com.

Comment

Mahsa Rostami Chaijan et al. Complement Ther Med. 2020 Nov.

. 2020 Nov:54:102544.

doi: 10.1016/j.ctim.2020.102544. Epub 2020 Aug 23.

¹ Department of Persian Medicine, Fasa University of Medical Sciences, Fasa, Iran.
² Traditional Medicine and Hydrotherapy Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
³ Department of Obstetrics and Gynecology, Richmond University Medical Center, Staten Island, New York, USA.
⁴ Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran; Department of Persian Medicine, Fasa University of Medical Sciences, Fasa, Iran. Electronic address: hashempur@gmail.com.

No abstract available

Comment on

The effects of eugenol nanoemulsion on pain caused by arteriovenous fistula cannulation in hemodialysis patients: A randomized double-blinded controlled cross-over trial.
Maghbool M, Khosravi T, Vojdani S, Chaijan MR, Esmaeili F, Amani A, Rezayat F, Nasimi Doost Azgomi R, Mehraban SS, Hashempur MH. Maghbool M, et al. Complement Ther Med. 2020 Aug;52:102440. doi: 10.1016/j.ctim.2020.102440. Epub 2020 May 16. Complement Ther Med. 2020. PMID: 32951708 Clinical Trial.